Related Experiment Video
Updated: Jun 23, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mumps: a year of enhanced surveillance in Catalonia, Spain
Angela Dominguez1, Manuel Oviedo, Nuria Torner
1Department of Public Health, University of Barcelona, Casanova 143, 08036 Barcelona, Spain. angela.dominguez@ub.edu
Abstract:
Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in > or =15 years (p=0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.
Insights
Mumps elimination requires laboratory confirmation of suspected cases, as the clinical case definition has a low positive predictive value (PPV). Even with high MMR vaccination, confirming mumps cases is crucial for disease control and assessing vaccine effectiveness.
Area of Science:
- Epidemiology
- Vaccinology
- Public Health
Background:
- Mumps is a vaccine-preventable illness targeted for global elimination.
- The positive predictive value (PPV) of clinical case definitions for mumps requires assessment to guide public health strategies.
- High measles, mumps, and rubella (MMR) vaccine coverage is essential for mumps control.
Purpose of the Study:
- To evaluate the positive predictive value (PPV) of the clinical case definition for mumps.
- To determine the necessity of laboratory confirmation for mumps surveillance and control in a high-vaccination setting.
Main Methods:
- Retrospective analysis of suspected mumps cases reported in Catalonia during 2007.
- Calculation of incidence rates for both clinically defined and laboratory-confirmed mumps cases.
- Assessment of the PPV of the clinical case definition, stratified by age group (<15 years and >=15 years).
Main Results:
- Of 410 suspected mumps cases, 348 met the clinical case definition and 159 were laboratory confirmed.
- The global PPV of the clinical case definition was 44.5%, with lower PPV in younger individuals (38.5% in <15 years) compared to older individuals (50% in >=15 years).
- A significant proportion (72.3%) of laboratory-confirmed mumps cases had received at least one dose of the MMR vaccine.
Conclusions:
- The clinical case definition for mumps has a suboptimal PPV, necessitating laboratory confirmation for accurate surveillance.
- Laboratory confirmation is vital for effective mumps control and for evaluating vaccine failure, even in populations with high MMR coverage.
- Continued high MMR vaccination coverage remains critical, alongside robust laboratory confirmation, to achieve mumps elimination goals.
More Related Videos
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Principles of Disease Surveillance
Investigation of Disease Outbreaks
Poliomyelitis
Arboviral Encephalitis
Viral Meningitis
Diphtheria